慢性髓性白血病 - - 对当前状况的回顾
Journal of insurance medicine (New York, N.Y.)
|September 16, 2025
概括
慢性髓性白血病 (CML) 是一种由费城染色体驱动的癌症. 氨酸激酶抑制剂 (TKIs) 有效地管理CML,一些患者实现了无治疗缓解.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 慢性髓性白血病 (CML) 是一种由费城染色体特征的骨髓增殖性新生体,这是BCR-ABL1融合基因的结果.
- 每10万人中CML发病率为1-2例,通过检测费城染色体来确认诊断.
研究的目的:
- 审查慢性髓性白血病 (CML) 的发病,诊断和治疗.
- 突出氨酸激酶抑制剂 (TKI) 对CML管理和患者结局的影响.
主要方法:
- 对CML科学文献的审查,重点关注遗传驱动因素,疾病阶段和治疗进展.
- 对氨酸激酶抑制剂 (TKI) 和全原造血干细胞移植 (SCT) 疗效的分析.
主要成果:
- BCR-ABL1融合基因驱动CML,疾病进展通过慢性,加速和爆发阶段.
- 氨酸激酶抑制剂 (TKIs) 显著改善了结果,特别是当在慢性阶段开始使用时.
- 全基性造血干细胞移植 (SCT) 为晚期或TKI不耐受的CML患者提供了替代方案.
结论:
- 使用TKIs的向治疗改变了CML治疗方法,改善了生存率和生活质量.
- 一部分CML患者可能在持续对TKI反应后实现无治疗缓解 (TFR).
- 对于特定的CML患者群体来说,SCT仍然是一个可行的选择.
关键词:
在CML中,CML是CML.慢性骨髓性白血病 慢性骨髓性白血病费城染色体是什么意思 费城染色体是什么意思染色体22的第22个染色体血液学 血液学 血液学死亡率 死亡率瘤学 在瘤学方面.承保是指承保的行为.更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.6K
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.3K
相关概念视频
Disorders of Leukocytes
1.8K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
